Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines
Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of pr...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Jane N Zuckerman [verfasserIn] Christoph Hatz [verfasserIn] Anu Kantele [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Expert Review of Vaccines - Taylor & Francis Group, 2023, 16(2017), 10, Seite 1029-1043 |
|---|---|
| Übergeordnetes Werk: |
volume:16 ; year:2017 ; number:10 ; pages:1029-1043 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.1080/14760584.2017.1374861 |
|---|
| Katalog-ID: |
DOAJ099443902 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ099443902 | ||
| 003 | DE-627 | ||
| 005 | 20240414033857.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240414s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14760584.2017.1374861 |2 doi | |
| 035 | |a (DE-627)DOAJ099443902 | ||
| 035 | |a (DE-599)DOAJaabc8e22393d4d92aacccc36c395a75b | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC31-1245 | |
| 100 | 0 | |a Jane N Zuckerman |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of preventive measures, especially vaccinations against typhoid and paratyphoid fever for travelers visiting endemic countries. Areas covered: This state-of-the-art review recapitulates the epidemiology and mechanisms of disease of typhoid and paratyphoid fever, depicts the perspective of non-endemic countries and travelers (VFRs), and collectively presents current European recommendations for typhoid fever vaccination. We provide a brief overview of available (and developmental) vaccines in Europe, present current data on cross-protection to S. Paratyphi, and aim to provide a background for typhoid vaccine decision-making in travelers. Expert commentary: European recommendations are not harmonized. Experts must assess vaccination of travelers based on current country-specific recommendations. Travel health practitioners should be aware of the issues surrounding vaccination of travelers and be motivated to increase awareness of typhoid and paratyphoid fever risks. | ||
| 650 | 4 | |a paratyphoid fever | |
| 650 | 4 | |a ty21a | |
| 650 | 4 | |a typhoid fever | |
| 650 | 4 | |a vaccine recommendations | |
| 650 | 4 | |a vi capsular polysaccharide | |
| 650 | 4 | |a visiting friends and relatives | |
| 653 | 0 | |a Internal medicine | |
| 700 | 0 | |a Christoph Hatz |e verfasserin |4 aut | |
| 700 | 0 | |a Anu Kantele |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Expert Review of Vaccines |d Taylor & Francis Group, 2023 |g 16(2017), 10, Seite 1029-1043 |w (DE-627)355690519 |w (DE-600)2090861-1 |x 17448395 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2017 |g number:10 |g pages:1029-1043 |
| 856 | 4 | 0 | |u https://doi.org/10.1080/14760584.2017.1374861 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/aabc8e22393d4d92aacccc36c395a75b |z kostenfrei |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14760584.2017.1374861 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1476-0584 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1744-8395 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a GBV_ILN_702 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a GBV_ILN_2190 | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2017 |e 10 |h 1029-1043 | ||
| author_variant |
j n z jnz c h ch a k ak |
|---|---|
| matchkey_str |
article:17448395:2017----::eiwfurntpodeevciecosrtcingisprtpodee |
| hierarchy_sort_str |
2017 |
| callnumber-subject-code |
RC |
| publishDate |
2017 |
| allfields |
10.1080/14760584.2017.1374861 doi (DE-627)DOAJ099443902 (DE-599)DOAJaabc8e22393d4d92aacccc36c395a75b DE-627 ger DE-627 rakwb eng RC31-1245 Jane N Zuckerman verfasserin aut Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of preventive measures, especially vaccinations against typhoid and paratyphoid fever for travelers visiting endemic countries. Areas covered: This state-of-the-art review recapitulates the epidemiology and mechanisms of disease of typhoid and paratyphoid fever, depicts the perspective of non-endemic countries and travelers (VFRs), and collectively presents current European recommendations for typhoid fever vaccination. We provide a brief overview of available (and developmental) vaccines in Europe, present current data on cross-protection to S. Paratyphi, and aim to provide a background for typhoid vaccine decision-making in travelers. Expert commentary: European recommendations are not harmonized. Experts must assess vaccination of travelers based on current country-specific recommendations. Travel health practitioners should be aware of the issues surrounding vaccination of travelers and be motivated to increase awareness of typhoid and paratyphoid fever risks. paratyphoid fever ty21a typhoid fever vaccine recommendations vi capsular polysaccharide visiting friends and relatives Internal medicine Christoph Hatz verfasserin aut Anu Kantele verfasserin aut In Expert Review of Vaccines Taylor & Francis Group, 2023 16(2017), 10, Seite 1029-1043 (DE-627)355690519 (DE-600)2090861-1 17448395 nnns volume:16 year:2017 number:10 pages:1029-1043 https://doi.org/10.1080/14760584.2017.1374861 kostenfrei https://doaj.org/article/aabc8e22393d4d92aacccc36c395a75b kostenfrei http://dx.doi.org/10.1080/14760584.2017.1374861 kostenfrei https://doaj.org/toc/1476-0584 Journal toc kostenfrei https://doaj.org/toc/1744-8395 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2190 AR 16 2017 10 1029-1043 |
| spelling |
10.1080/14760584.2017.1374861 doi (DE-627)DOAJ099443902 (DE-599)DOAJaabc8e22393d4d92aacccc36c395a75b DE-627 ger DE-627 rakwb eng RC31-1245 Jane N Zuckerman verfasserin aut Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of preventive measures, especially vaccinations against typhoid and paratyphoid fever for travelers visiting endemic countries. Areas covered: This state-of-the-art review recapitulates the epidemiology and mechanisms of disease of typhoid and paratyphoid fever, depicts the perspective of non-endemic countries and travelers (VFRs), and collectively presents current European recommendations for typhoid fever vaccination. We provide a brief overview of available (and developmental) vaccines in Europe, present current data on cross-protection to S. Paratyphi, and aim to provide a background for typhoid vaccine decision-making in travelers. Expert commentary: European recommendations are not harmonized. Experts must assess vaccination of travelers based on current country-specific recommendations. Travel health practitioners should be aware of the issues surrounding vaccination of travelers and be motivated to increase awareness of typhoid and paratyphoid fever risks. paratyphoid fever ty21a typhoid fever vaccine recommendations vi capsular polysaccharide visiting friends and relatives Internal medicine Christoph Hatz verfasserin aut Anu Kantele verfasserin aut In Expert Review of Vaccines Taylor & Francis Group, 2023 16(2017), 10, Seite 1029-1043 (DE-627)355690519 (DE-600)2090861-1 17448395 nnns volume:16 year:2017 number:10 pages:1029-1043 https://doi.org/10.1080/14760584.2017.1374861 kostenfrei https://doaj.org/article/aabc8e22393d4d92aacccc36c395a75b kostenfrei http://dx.doi.org/10.1080/14760584.2017.1374861 kostenfrei https://doaj.org/toc/1476-0584 Journal toc kostenfrei https://doaj.org/toc/1744-8395 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2190 AR 16 2017 10 1029-1043 |
| allfields_unstemmed |
10.1080/14760584.2017.1374861 doi (DE-627)DOAJ099443902 (DE-599)DOAJaabc8e22393d4d92aacccc36c395a75b DE-627 ger DE-627 rakwb eng RC31-1245 Jane N Zuckerman verfasserin aut Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of preventive measures, especially vaccinations against typhoid and paratyphoid fever for travelers visiting endemic countries. Areas covered: This state-of-the-art review recapitulates the epidemiology and mechanisms of disease of typhoid and paratyphoid fever, depicts the perspective of non-endemic countries and travelers (VFRs), and collectively presents current European recommendations for typhoid fever vaccination. We provide a brief overview of available (and developmental) vaccines in Europe, present current data on cross-protection to S. Paratyphi, and aim to provide a background for typhoid vaccine decision-making in travelers. Expert commentary: European recommendations are not harmonized. Experts must assess vaccination of travelers based on current country-specific recommendations. Travel health practitioners should be aware of the issues surrounding vaccination of travelers and be motivated to increase awareness of typhoid and paratyphoid fever risks. paratyphoid fever ty21a typhoid fever vaccine recommendations vi capsular polysaccharide visiting friends and relatives Internal medicine Christoph Hatz verfasserin aut Anu Kantele verfasserin aut In Expert Review of Vaccines Taylor & Francis Group, 2023 16(2017), 10, Seite 1029-1043 (DE-627)355690519 (DE-600)2090861-1 17448395 nnns volume:16 year:2017 number:10 pages:1029-1043 https://doi.org/10.1080/14760584.2017.1374861 kostenfrei https://doaj.org/article/aabc8e22393d4d92aacccc36c395a75b kostenfrei http://dx.doi.org/10.1080/14760584.2017.1374861 kostenfrei https://doaj.org/toc/1476-0584 Journal toc kostenfrei https://doaj.org/toc/1744-8395 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2190 AR 16 2017 10 1029-1043 |
| allfieldsGer |
10.1080/14760584.2017.1374861 doi (DE-627)DOAJ099443902 (DE-599)DOAJaabc8e22393d4d92aacccc36c395a75b DE-627 ger DE-627 rakwb eng RC31-1245 Jane N Zuckerman verfasserin aut Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of preventive measures, especially vaccinations against typhoid and paratyphoid fever for travelers visiting endemic countries. Areas covered: This state-of-the-art review recapitulates the epidemiology and mechanisms of disease of typhoid and paratyphoid fever, depicts the perspective of non-endemic countries and travelers (VFRs), and collectively presents current European recommendations for typhoid fever vaccination. We provide a brief overview of available (and developmental) vaccines in Europe, present current data on cross-protection to S. Paratyphi, and aim to provide a background for typhoid vaccine decision-making in travelers. Expert commentary: European recommendations are not harmonized. Experts must assess vaccination of travelers based on current country-specific recommendations. Travel health practitioners should be aware of the issues surrounding vaccination of travelers and be motivated to increase awareness of typhoid and paratyphoid fever risks. paratyphoid fever ty21a typhoid fever vaccine recommendations vi capsular polysaccharide visiting friends and relatives Internal medicine Christoph Hatz verfasserin aut Anu Kantele verfasserin aut In Expert Review of Vaccines Taylor & Francis Group, 2023 16(2017), 10, Seite 1029-1043 (DE-627)355690519 (DE-600)2090861-1 17448395 nnns volume:16 year:2017 number:10 pages:1029-1043 https://doi.org/10.1080/14760584.2017.1374861 kostenfrei https://doaj.org/article/aabc8e22393d4d92aacccc36c395a75b kostenfrei http://dx.doi.org/10.1080/14760584.2017.1374861 kostenfrei https://doaj.org/toc/1476-0584 Journal toc kostenfrei https://doaj.org/toc/1744-8395 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2190 AR 16 2017 10 1029-1043 |
| allfieldsSound |
10.1080/14760584.2017.1374861 doi (DE-627)DOAJ099443902 (DE-599)DOAJaabc8e22393d4d92aacccc36c395a75b DE-627 ger DE-627 rakwb eng RC31-1245 Jane N Zuckerman verfasserin aut Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of preventive measures, especially vaccinations against typhoid and paratyphoid fever for travelers visiting endemic countries. Areas covered: This state-of-the-art review recapitulates the epidemiology and mechanisms of disease of typhoid and paratyphoid fever, depicts the perspective of non-endemic countries and travelers (VFRs), and collectively presents current European recommendations for typhoid fever vaccination. We provide a brief overview of available (and developmental) vaccines in Europe, present current data on cross-protection to S. Paratyphi, and aim to provide a background for typhoid vaccine decision-making in travelers. Expert commentary: European recommendations are not harmonized. Experts must assess vaccination of travelers based on current country-specific recommendations. Travel health practitioners should be aware of the issues surrounding vaccination of travelers and be motivated to increase awareness of typhoid and paratyphoid fever risks. paratyphoid fever ty21a typhoid fever vaccine recommendations vi capsular polysaccharide visiting friends and relatives Internal medicine Christoph Hatz verfasserin aut Anu Kantele verfasserin aut In Expert Review of Vaccines Taylor & Francis Group, 2023 16(2017), 10, Seite 1029-1043 (DE-627)355690519 (DE-600)2090861-1 17448395 nnns volume:16 year:2017 number:10 pages:1029-1043 https://doi.org/10.1080/14760584.2017.1374861 kostenfrei https://doaj.org/article/aabc8e22393d4d92aacccc36c395a75b kostenfrei http://dx.doi.org/10.1080/14760584.2017.1374861 kostenfrei https://doaj.org/toc/1476-0584 Journal toc kostenfrei https://doaj.org/toc/1744-8395 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2190 AR 16 2017 10 1029-1043 |
| language |
English |
| source |
In Expert Review of Vaccines 16(2017), 10, Seite 1029-1043 volume:16 year:2017 number:10 pages:1029-1043 |
| sourceStr |
In Expert Review of Vaccines 16(2017), 10, Seite 1029-1043 volume:16 year:2017 number:10 pages:1029-1043 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
paratyphoid fever ty21a typhoid fever vaccine recommendations vi capsular polysaccharide visiting friends and relatives Internal medicine |
| isfreeaccess_bool |
true |
| container_title |
Expert Review of Vaccines |
| authorswithroles_txt_mv |
Jane N Zuckerman @@aut@@ Christoph Hatz @@aut@@ Anu Kantele @@aut@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
355690519 |
| id |
DOAJ099443902 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ099443902</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414033857.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240414s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1080/14760584.2017.1374861</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ099443902</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJaabc8e22393d4d92aacccc36c395a75b</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC31-1245</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Jane N Zuckerman</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of preventive measures, especially vaccinations against typhoid and paratyphoid fever for travelers visiting endemic countries. Areas covered: This state-of-the-art review recapitulates the epidemiology and mechanisms of disease of typhoid and paratyphoid fever, depicts the perspective of non-endemic countries and travelers (VFRs), and collectively presents current European recommendations for typhoid fever vaccination. We provide a brief overview of available (and developmental) vaccines in Europe, present current data on cross-protection to S. Paratyphi, and aim to provide a background for typhoid vaccine decision-making in travelers. Expert commentary: European recommendations are not harmonized. Experts must assess vaccination of travelers based on current country-specific recommendations. Travel health practitioners should be aware of the issues surrounding vaccination of travelers and be motivated to increase awareness of typhoid and paratyphoid fever risks.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">paratyphoid fever</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ty21a</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">typhoid fever</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vaccine recommendations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vi capsular polysaccharide</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">visiting friends and relatives</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Internal medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Christoph Hatz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Anu Kantele</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Expert Review of Vaccines</subfield><subfield code="d">Taylor & Francis Group, 2023</subfield><subfield code="g">16(2017), 10, Seite 1029-1043</subfield><subfield code="w">(DE-627)355690519</subfield><subfield code="w">(DE-600)2090861-1</subfield><subfield code="x">17448395</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:1029-1043</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1080/14760584.2017.1374861</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/aabc8e22393d4d92aacccc36c395a75b</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1080/14760584.2017.1374861</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1476-0584</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1744-8395</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2017</subfield><subfield code="e">10</subfield><subfield code="h">1029-1043</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
Jane N Zuckerman |
| spellingShingle |
Jane N Zuckerman misc RC31-1245 misc paratyphoid fever misc ty21a misc typhoid fever misc vaccine recommendations misc vi capsular polysaccharide misc visiting friends and relatives misc Internal medicine Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines |
| authorStr |
Jane N Zuckerman |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)355690519 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
RC31-1245 |
| illustrated |
Not Illustrated |
| issn |
17448395 |
| topic_title |
RC31-1245 Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines paratyphoid fever ty21a typhoid fever vaccine recommendations vi capsular polysaccharide visiting friends and relatives |
| topic |
misc RC31-1245 misc paratyphoid fever misc ty21a misc typhoid fever misc vaccine recommendations misc vi capsular polysaccharide misc visiting friends and relatives misc Internal medicine |
| topic_unstemmed |
misc RC31-1245 misc paratyphoid fever misc ty21a misc typhoid fever misc vaccine recommendations misc vi capsular polysaccharide misc visiting friends and relatives misc Internal medicine |
| topic_browse |
misc RC31-1245 misc paratyphoid fever misc ty21a misc typhoid fever misc vaccine recommendations misc vi capsular polysaccharide misc visiting friends and relatives misc Internal medicine |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Expert Review of Vaccines |
| hierarchy_parent_id |
355690519 |
| hierarchy_top_title |
Expert Review of Vaccines |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)355690519 (DE-600)2090861-1 |
| title |
Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines |
| ctrlnum |
(DE-627)DOAJ099443902 (DE-599)DOAJaabc8e22393d4d92aacccc36c395a75b |
| title_full |
Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines |
| author_sort |
Jane N Zuckerman |
| journal |
Expert Review of Vaccines |
| journalStr |
Expert Review of Vaccines |
| callnumber-first-code |
R |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
txt |
| container_start_page |
1029 |
| author_browse |
Jane N Zuckerman Christoph Hatz Anu Kantele |
| container_volume |
16 |
| class |
RC31-1245 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Jane N Zuckerman |
| doi_str_mv |
10.1080/14760584.2017.1374861 |
| author2-role |
verfasserin |
| title_sort |
review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the european guidelines |
| callnumber |
RC31-1245 |
| title_auth |
Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines |
| abstract |
Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of preventive measures, especially vaccinations against typhoid and paratyphoid fever for travelers visiting endemic countries. Areas covered: This state-of-the-art review recapitulates the epidemiology and mechanisms of disease of typhoid and paratyphoid fever, depicts the perspective of non-endemic countries and travelers (VFRs), and collectively presents current European recommendations for typhoid fever vaccination. We provide a brief overview of available (and developmental) vaccines in Europe, present current data on cross-protection to S. Paratyphi, and aim to provide a background for typhoid vaccine decision-making in travelers. Expert commentary: European recommendations are not harmonized. Experts must assess vaccination of travelers based on current country-specific recommendations. Travel health practitioners should be aware of the issues surrounding vaccination of travelers and be motivated to increase awareness of typhoid and paratyphoid fever risks. |
| abstractGer |
Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of preventive measures, especially vaccinations against typhoid and paratyphoid fever for travelers visiting endemic countries. Areas covered: This state-of-the-art review recapitulates the epidemiology and mechanisms of disease of typhoid and paratyphoid fever, depicts the perspective of non-endemic countries and travelers (VFRs), and collectively presents current European recommendations for typhoid fever vaccination. We provide a brief overview of available (and developmental) vaccines in Europe, present current data on cross-protection to S. Paratyphi, and aim to provide a background for typhoid vaccine decision-making in travelers. Expert commentary: European recommendations are not harmonized. Experts must assess vaccination of travelers based on current country-specific recommendations. Travel health practitioners should be aware of the issues surrounding vaccination of travelers and be motivated to increase awareness of typhoid and paratyphoid fever risks. |
| abstract_unstemmed |
Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of preventive measures, especially vaccinations against typhoid and paratyphoid fever for travelers visiting endemic countries. Areas covered: This state-of-the-art review recapitulates the epidemiology and mechanisms of disease of typhoid and paratyphoid fever, depicts the perspective of non-endemic countries and travelers (VFRs), and collectively presents current European recommendations for typhoid fever vaccination. We provide a brief overview of available (and developmental) vaccines in Europe, present current data on cross-protection to S. Paratyphi, and aim to provide a background for typhoid vaccine decision-making in travelers. Expert commentary: European recommendations are not harmonized. Experts must assess vaccination of travelers based on current country-specific recommendations. Travel health practitioners should be aware of the issues surrounding vaccination of travelers and be motivated to increase awareness of typhoid and paratyphoid fever risks. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2190 |
| container_issue |
10 |
| title_short |
Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines |
| url |
https://doi.org/10.1080/14760584.2017.1374861 https://doaj.org/article/aabc8e22393d4d92aacccc36c395a75b http://dx.doi.org/10.1080/14760584.2017.1374861 https://doaj.org/toc/1476-0584 https://doaj.org/toc/1744-8395 |
| remote_bool |
true |
| author2 |
Christoph Hatz Anu Kantele |
| author2Str |
Christoph Hatz Anu Kantele |
| ppnlink |
355690519 |
| callnumber-subject |
RC - Internal Medicine |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.1080/14760584.2017.1374861 |
| callnumber-a |
RC31-1245 |
| up_date |
2024-07-03T22:48:55.581Z |
| _version_ |
1803599935525879808 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ099443902</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414033857.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240414s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1080/14760584.2017.1374861</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ099443902</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJaabc8e22393d4d92aacccc36c395a75b</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC31-1245</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Jane N Zuckerman</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction: Typhoid and paratyphoid fever remain a global health problem, which – in non-endemic countries – are mainly seen in travelers, particularly in VFRs (visiting friends and relatives), with occasional local outbreaks occurring. A rise in anti-microbial resistance emphasizes the role of preventive measures, especially vaccinations against typhoid and paratyphoid fever for travelers visiting endemic countries. Areas covered: This state-of-the-art review recapitulates the epidemiology and mechanisms of disease of typhoid and paratyphoid fever, depicts the perspective of non-endemic countries and travelers (VFRs), and collectively presents current European recommendations for typhoid fever vaccination. We provide a brief overview of available (and developmental) vaccines in Europe, present current data on cross-protection to S. Paratyphi, and aim to provide a background for typhoid vaccine decision-making in travelers. Expert commentary: European recommendations are not harmonized. Experts must assess vaccination of travelers based on current country-specific recommendations. Travel health practitioners should be aware of the issues surrounding vaccination of travelers and be motivated to increase awareness of typhoid and paratyphoid fever risks.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">paratyphoid fever</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ty21a</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">typhoid fever</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vaccine recommendations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vi capsular polysaccharide</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">visiting friends and relatives</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Internal medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Christoph Hatz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Anu Kantele</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Expert Review of Vaccines</subfield><subfield code="d">Taylor & Francis Group, 2023</subfield><subfield code="g">16(2017), 10, Seite 1029-1043</subfield><subfield code="w">(DE-627)355690519</subfield><subfield code="w">(DE-600)2090861-1</subfield><subfield code="x">17448395</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:10</subfield><subfield code="g">pages:1029-1043</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1080/14760584.2017.1374861</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/aabc8e22393d4d92aacccc36c395a75b</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1080/14760584.2017.1374861</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1476-0584</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1744-8395</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2017</subfield><subfield code="e">10</subfield><subfield code="h">1029-1043</subfield></datafield></record></collection>
|
| score |
7.399685 |